Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock Short Interest Declines 64.1%

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was the recipient of a large decrease in short interest in the month of October. As of October 30th, there was short interest totaling 112,756 shares, a decrease of 64.1% from the October 15th total of 313,781 shares. Based on an average trading volume of 907,649 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the company are sold short.

Bayer Aktiengesellschaft Stock Performance

BAYRY stock traded down $0.01 during midday trading on Friday, reaching $15.66. The stock had a trading volume of 545,421 shares, compared to its average volume of 913,557. The firm has a fifty day simple moving average of $13.66 and a two-hundred day simple moving average of $12.67. Bayer Aktiengesellschaft has a 52-week low of $7.65 and a 52-week high of $15.98. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.67 and a current ratio of 1.04. The stock has a market cap of $61.54 billion, a PE ratio of -37.28, a P/E/G ratio of 1.96 and a beta of 0.57.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.02). Bayer Aktiengesellschaft had a negative net margin of 3.12% and a positive return on equity of 16.10%. The firm had revenue of $11.25 billion during the quarter, compared to analyst estimates of $11.21 billion. As a group, equities research analysts anticipate that Bayer Aktiengesellschaft will post 1.28 EPS for the current year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft is a German life sciences company headquartered in Leverkusen. Founded in 1863, it develops products and services in pharmaceuticals, consumer health and agriculture. Its Pharmaceuticals business offers prescription medicines, including treatments in areas such as cardiovascular disease, oncology, women’s health and eye care. Consumer Health sells nonprescription medicines and self-care products, with brands including Claritin, Aleve and One A Day. Through its Crop Science business, Bayer provides seeds, crop protection products and agricultural solutions for farmers.